Zdrowie i gospodarka · 27/06/2016
FDA Extends Comment Period for Direct-Acting Antiviral Drug Guidance
The FDA is extending the comment period for a draft guidance on developing direct-acting antiviral drugs for treating chronic hepatitis C virus infection, originally set to close on July 5, 2016, due to maintenance on the Federal eRulemaking portal.